3/11
08:07 pm
hims
Why the Market Dipped But Hims & Hers Health, Inc. (HIMS) Gained Today [Yahoo! Finance]
Low
Report
Why the Market Dipped But Hims & Hers Health, Inc. (HIMS) Gained Today [Yahoo! Finance]
3/10
09:24 am
hims
Bet on DuPont Analysis & Pick 5 Quality Stocks [Yahoo! Finance]
Low
Report
Bet on DuPont Analysis & Pick 5 Quality Stocks [Yahoo! Finance]
3/7
09:07 am
hims
https://seekingalpha.com/article/4765662-hims-and-hers-odds-are-in-your-favor-how-to-take-advantage [Seeking Alpha]
Medium
Report
https://seekingalpha.com/article/4765662-hims-and-hers-odds-are-in-your-favor-how-to-take-advantage [Seeking Alpha]
3/6
01:30 pm
hims
Hims & Hers Health, Inc. (NYSE: HIMS) had its "underperform" rating re-affirmed by analysts at Bank of America Co.. They now have a $21.00 price target on the stock.
Low
Report
Hims & Hers Health, Inc. (NYSE: HIMS) had its "underperform" rating re-affirmed by analysts at Bank of America Co.. They now have a $21.00 price target on the stock.
3/6
11:35 am
hims
Hims & Hers Health, Inc. (NYSE: HIMS) had its "sell" rating re-affirmed by analysts at Citigroup Inc.. They now have a $27.00 price target on the stock.
Medium
Report
Hims & Hers Health, Inc. (NYSE: HIMS) had its "sell" rating re-affirmed by analysts at Citigroup Inc.. They now have a $27.00 price target on the stock.
3/6
05:48 am
hims
Why Novo Nordisk Stock Outpaced the Market Today and Hims & Hers Lagged It [Yahoo! Finance]
High
Report
Why Novo Nordisk Stock Outpaced the Market Today and Hims & Hers Lagged It [Yahoo! Finance]
3/3
02:11 pm
hims
Hims & Hers Health (NYSE:HIMS) Jumps 40% After Projecting US$2.3 Billion Revenue for 2025 [Yahoo! Finance]
Low
Report
Hims & Hers Health (NYSE:HIMS) Jumps 40% After Projecting US$2.3 Billion Revenue for 2025 [Yahoo! Finance]
3/1
08:33 pm
hims
Why Hims & Hers Health Stock Sank This Week [Yahoo! Finance]
Medium
Report
Why Hims & Hers Health Stock Sank This Week [Yahoo! Finance]
3/1
07:24 am
hims
Hims & Hers Stocks Sinks Despite Huge Revenue Growth. Is This a Buying Opportunity in the Stock? [Yahoo! Finance]
Medium
Report
Hims & Hers Stocks Sinks Despite Huge Revenue Growth. Is This a Buying Opportunity in the Stock? [Yahoo! Finance]
2/28
09:06 am
hims
Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up [Yahoo! Finance]
High
Report
Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up [Yahoo! Finance]
2/26
08:58 am
hims
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Truist Financial Co. from $24.00 to $39.00. They now have a "hold" rating on the stock.
Low
Report
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Truist Financial Co. from $24.00 to $39.00. They now have a "hold" rating on the stock.
2/26
06:44 am
hims
Hims & Hers Health Full Year 2024 Earnings: In Line With Expectations [Yahoo! Finance]
Medium
Report
Hims & Hers Health Full Year 2024 Earnings: In Line With Expectations [Yahoo! Finance]
2/25
02:29 pm
hims
https://seekingalpha.com/article/4761790-hims-and-hers-health-focus-on-the-future-not-glp-1s [Seeking Alpha]
Low
Report
https://seekingalpha.com/article/4761790-hims-and-hers-health-focus-on-the-future-not-glp-1s [Seeking Alpha]
2/25
02:24 pm
hims
Why Hims & Hers Health (HIMS) Shares Are Getting Obliterated Today [Yahoo! Finance]
Low
Report
Why Hims & Hers Health (HIMS) Shares Are Getting Obliterated Today [Yahoo! Finance]
2/25
12:55 pm
hims
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Leerink Partners from $24.00 to $40.00. They now have a "market perform" rating on the stock.
Medium
Report
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Leerink Partners from $24.00 to $40.00. They now have a "market perform" rating on the stock.
2/25
11:51 am
hims
Home Depot earnings, Nvidia, Krispy Kreme CEO: Morning Brief [Yahoo! Finance]
Medium
Report
Home Depot earnings, Nvidia, Krispy Kreme CEO: Morning Brief [Yahoo! Finance]
2/25
11:43 am
hims
Home Depot earnings, Nvidia, Krispy Kreme CEO: Morning Brief [Yahoo! Finance Canada]
Medium
Report
Home Depot earnings, Nvidia, Krispy Kreme CEO: Morning Brief [Yahoo! Finance Canada]
2/25
10:57 am
hims
Hims & Hers shares plunge 28% on concerns over weight loss business, margins [CNBC]
Medium
Report
Hims & Hers shares plunge 28% on concerns over weight loss business, margins [CNBC]
2/25
10:21 am
hims
Stock market stalls as Wall Street anxiously waits on Trump's tariffs and more [Yahoo! Finance]
Medium
Report
Stock market stalls as Wall Street anxiously waits on Trump's tariffs and more [Yahoo! Finance]
2/25
09:31 am
hims
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Piper Sandler from $24.00 to $35.00. They now have a "neutral" rating on the stock.
Low
Report
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Piper Sandler from $24.00 to $35.00. They now have a "neutral" rating on the stock.
2/25
08:42 am
hims
Buy, Sell, Or Hold HIMS Stock At $40? [Forbes]
Low
Report
Buy, Sell, Or Hold HIMS Stock At $40? [Forbes]
2/25
08:21 am
hims
Why Hims & Hers Health Inc. (HIMS) Went Up On Monday? [Yahoo! Finance]
Low
Report
Why Hims & Hers Health Inc. (HIMS) Went Up On Monday? [Yahoo! Finance]
2/25
08:18 am
hims
Tandem Diabetes (TNDM) Q4 Earnings: What To Expect [Yahoo! Finance]
Low
Report
Tandem Diabetes (TNDM) Q4 Earnings: What To Expect [Yahoo! Finance]
2/25
08:00 am
hims
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Needham & Company LLC from $31.00 to $61.00. They now have a "buy" rating on the stock.
Medium
Report
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Needham & Company LLC from $31.00 to $61.00. They now have a "buy" rating on the stock.
2/25
08:00 am
hims
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Citigroup Inc. from $25.00 to $27.00. They now have a "sell" rating on the stock.
Medium
Report
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Citigroup Inc. from $25.00 to $27.00. They now have a "sell" rating on the stock.